Boosting BCG Vaccination with Recombinant HBHA to Fight Tuberculosis
Author Information
Author(s): G. G. Guerrero, C. Locht
Primary Institution: INSERM U1019, Lille, France
Hypothesis
Does boosting with recombinant, non-methylated HBHA enhance protection of BCG-primed newborn mice against Mycobacterium tuberculosis infection?
Conclusion
Boosting with recombinant HBHA enhances protection in the spleen but not in the lungs against aerosol infection in BCG-primed mice.
Supporting Evidence
- Boosting with recombinant HBHA significantly reduced bacterial load in the spleen.
- Protection in the lungs was not enhanced by rHBHA after aerosol challenge.
- High levels of IL-12 were produced in boosted mice after infection.
Takeaway
Researchers found that a new vaccine booster can help protect mice from tuberculosis better when given after the initial vaccine.
Methodology
Newborn mice were vaccinated with BCG and then boosted with recombinant HBHA, followed by infection with M. tuberculosis to measure bacterial load in organs.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Newborn BALB/c mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website